Joint Formulary & PAD

Amitriptyline hydrochloride - Depression

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Oral solution
  • Tablets
Associated Icons :
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Amitriptyline hydrochloride
Indication :
Depression
Group Name :
Keywords :
tricyclic antidepressants, TCAs
Brand Names Include :
Important Information :

Initiation and stabilisation by the Mental Health specialist team for a minimum of 3 months before any transfer of prescribing.

Exception - the specialist team may request this treatment is restarted in patients who have previously benefitted.

Not for routine initiation in new patients - risks of toxicity in overdose.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0